News

Tirzepatide vs. Semaglutide: FDA Approval and Efficacy Data
Tirzepatide and semaglutide show distinct FDA approval timelines and efficacy profiles. Tirzepatide's dual GIP-GLP-1 mechanism achieved faster approval and superior weight loss outcomes in regulatory trials. Read more...